(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study.
The law follows the passage of Legislative Bill 92 in 2023 and includes a provision that required insurance plans to cover screening colonoscopies, as well as an annual stool-based preventative ...